Two interesting new X-ray structures of negative allosteric modulator (NAM) ligands for the mGlu<sub>5</sub> receptor, M-MPEP (<b>3</b>) and fenobam (<b>4</b>), are reported. The new structures show how the binding of the ligands induces different receptor water channel conformations to previously published structures. The structure of fenobam, where a urea replaces the acetylenic linker in M-MPEP and mavoglurant, reveals a binding mode where the ligand is rotated by 180° compared to a previously proposed docking model. The need for multiple ligand structures for accurate GPCR structure-based drug design is demonstrated by the different growing vectors identified for the head groups of M-MPEP and mavoglurant and by the unexpected water-medi...
Positive allosteric modulators (PAMs) of metabotropic glutamate receptor type 5 (mGluR5), a prototyp...
Covalent labeling of G protein-coupled receptors (GPCRs) by small molecules is a powerful approach t...
G-protein coupled receptors (GPCRs) are targets for 1/3 of the drugs available on the market making ...
Two interesting new X-ray structures of negative allosteric modulator (NAM) ligands for the mGlu<sub...
Metabotropic glutamate receptor 5 (mGlu5) is a biological target implicated in major neurological an...
International audienceRecently determined structures of class C G protein-coupled receptors (GPCRs) ...
The metabotropic glutamate 5 (mGlu5) receptor is a class C G protein-coupled receptor (GPCR) that is...
Metabotropic glutamate receptors (mGluRs) are high-profile G-protein coupled receptors drug targets ...
Recently determined structures of class C G protein-coupled receptors (GPCRs) revealed the location ...
Drug discovery programs increasingly are focusing on allosteric modulators as ameans tomodify the ac...
A common metabotropic glutamate receptor 5 (mGlu<sub>5</sub>) allosteric site is known to accommodat...
Covalent labeling of G protein-coupled receptors (GPCRs) by small molecules is a powerful approach ...
Covalent labeling of G protein-coupled receptors (GPCRs) by small molecules is a powerful approach t...
G protein-coupled receptors (GPCRs) are integral membrane proteins responsible for signal transducti...
Metabotropic glutamate (mGlu) receptors are a family of eight GPCRs that are attractive drug discove...
Positive allosteric modulators (PAMs) of metabotropic glutamate receptor type 5 (mGluR5), a prototyp...
Covalent labeling of G protein-coupled receptors (GPCRs) by small molecules is a powerful approach t...
G-protein coupled receptors (GPCRs) are targets for 1/3 of the drugs available on the market making ...
Two interesting new X-ray structures of negative allosteric modulator (NAM) ligands for the mGlu<sub...
Metabotropic glutamate receptor 5 (mGlu5) is a biological target implicated in major neurological an...
International audienceRecently determined structures of class C G protein-coupled receptors (GPCRs) ...
The metabotropic glutamate 5 (mGlu5) receptor is a class C G protein-coupled receptor (GPCR) that is...
Metabotropic glutamate receptors (mGluRs) are high-profile G-protein coupled receptors drug targets ...
Recently determined structures of class C G protein-coupled receptors (GPCRs) revealed the location ...
Drug discovery programs increasingly are focusing on allosteric modulators as ameans tomodify the ac...
A common metabotropic glutamate receptor 5 (mGlu<sub>5</sub>) allosteric site is known to accommodat...
Covalent labeling of G protein-coupled receptors (GPCRs) by small molecules is a powerful approach ...
Covalent labeling of G protein-coupled receptors (GPCRs) by small molecules is a powerful approach t...
G protein-coupled receptors (GPCRs) are integral membrane proteins responsible for signal transducti...
Metabotropic glutamate (mGlu) receptors are a family of eight GPCRs that are attractive drug discove...
Positive allosteric modulators (PAMs) of metabotropic glutamate receptor type 5 (mGluR5), a prototyp...
Covalent labeling of G protein-coupled receptors (GPCRs) by small molecules is a powerful approach t...
G-protein coupled receptors (GPCRs) are targets for 1/3 of the drugs available on the market making ...